SEC Form 4 research
| Issuer | CITY THERAPEUTICS, INC. |
|---|---|
| Tickers | CTY |
| Reporting owners | 16 |
| Officers and directors | 1 |
| Last public filing | 2026-10-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-19 | ARCH Venture Fund XII, L.P., ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, Burow Kristina, CRANDELL KEITH, GILLIS STEVEN | P | 170,000 | $18 | Not reported |
| 2026-10-19 | 2026-10-19 | NELSEN ROBERT | P | 170,000 | $18 | Not reported |
| 2026-10-19 | 2026-10-15 | NELSEN ROBERT | A | 22,649 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | MARAGANORE JOHN | A | 22,649 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | Nochur Sara | A | 22,649 | $0 | Not reported |
| 2026-10-19 | 2026-10-19 | ORTH ANDREW C. | A | 77,979 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | Philip Ron M | A | 22,649 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | Greene Barry E | A | 22,649 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.